Borderline Resectable Pancreatic Carcinoma
2 clinical trials · Condition
◉ Watch Borderline Resectable Pancreatic Carcinoma
| Record | Firm | Date |
|---|---|---|
| Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC (NCT06714604) | Sahlgrenska University Hospital | 2023-10-18 |
| Stereotactic Magnetic Resonance Guided Radiation Therapy (NCT04115254) | Dana-Farber Cancer Institute | 2019-10-22 |
Track Borderline Resectable Pancreatic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.